Paroxysmal Sympathetic Hyperactivity: A Structured Approach for Clinical Practice.

Paroxysmal sympathetic hyperactivity is a neurological syndrome characterized by sudden episodes of sympathetic overactivity often triggered by non-noxious stimuli. First described by Wilder Penfield in 1929, it commonly follows severe brain injury and is associated with diffuse lesions involving diencephalic and brainstem structures. Its pathophysiology is not completely understood, but it is believed to result from an imbalance between excitatory and inhibitory pathways within the central nervous system. Diagnosis is clinical, based on exclusion of alternative causes and supported by the Paroxysmal Sympathetic Hyperactivity Assessment Measure. Management includes both pharmacological and non-pharmacological strategies. Despite growing recognition, clinical approaches remain heterogeneous. Further research is needed to clarify mechanisms and develop standardized, evidence-based diagnostic and treatment guidelines to improve outcomes.